RACHEL DAWN SPAYD
Allopathic & Osteopathic Physicians|Family Medicine MULLICA HILL, NJ NPI 1508440322
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine NJ ABBVIE INC. All categories
General Payments — all program years on this page
$184.39
- Category: General Payments
- Program years: PY2023–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $142.32 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $142.32 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $61.11 | 4 |
| Novo Nordisk AS | $47.45 | 3 |
| GlaxoSmithKline, LLC. | $16.91 | 1 |
| Lilly USA, LLC | $16.85 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097369427 | Novo Nordisk Inc | $18.03 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097390352 | Novo Nordisk Inc | $13.30 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097427268 | Novo Nordisk Inc | $16.12 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106144662 | ABBVIE INC. | $13.21 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106144664 | ABBVIE INC. | $16.17 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106144666 | ABBVIE INC. | $16.58 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106144668 | ABBVIE INC. | $15.15 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116665385 | GlaxoSmithKline, LLC. | $16.91 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135300563 | Lilly USA, LLC | $16.85 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.